Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Peptic Ulcer Market Over the Coming Decade?

Recently, the market size for peptic ulcers has been experiencing consistent growth. Projections indicate that it will rise from $4.1 billion in 2024 to $4.24 billion in 2025, showing a compound annual growth rate (CAGR) of 3.5%. Factors contributing to this increase during the historic period include a higher prevalence of helicobacter pylori infections, increased use of nonsteroidal anti-inflammatory drugs (NSAIDs), shifts in lifestyle and dietary practices, educational programs and awareness drives, along with an emphasis on managing stress.

The future market size of peptic ulcers is estimated to grow consistently, with a projection to reach $4.91 billion by 2029 at a compound annual growth rate (CAGR) of 3.7%. The projected growth during the forecast period can be credited to the development of new therapies and treatment methods, the rise in the elderly population, utilisation of precision medicine, prevention strategies and health improvement initiatives, as well as ongoing research and clinical trials. Key trends for the forecast period consist of the implementation of digital health solutions, enhancement in treatment procedures, growing instances of helicobacter pylori contamination, integration of diagnostic imaging technologies, and an increased inclination towards combination therapies.

What Factors Are Propelling the Growth of the Peptic Ulcer Market from 2025 to 2034?

The peptic ulcer market is anticipated to grow due to the increasing occurrence of obesity. Characterized by an unhealthy accumulation of body fat leading to a body mass index (BMI) of 30 or more, obesity is a medical condition that can result from genes, environment, and lifestyle choices, such as inactive lifestyle and unhealthy eating habits. The excess body weight causes an overproduction of stomach acid, weakens the stomach’s protective lining, and helps in the formation of peptic ulcers. Inflammation in the gut, prompted by obesity, can also lead to peptic ulcers. The Centers for Disease Control and Prevention reported in September 2024 that from August 2021 to August 2023, the percentage of adults suffering from obesity was 40.3%, with men accounting for 39.2% and women for 41.3%. Consequently, the escalating obesity rates contribute to the expansion of the peptic ulcer market.

Peptic Ulcer Market Driver: Peptic Ulcer Market Soars Due to Increased Smoking

Explore Comprehensive Insights Into The Global Peptic Ulcer Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp

What Are the Major Players Making an Impact in the Peptic Ulcer Market’s Growth?

Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

Which Upcoming Trends Are Set to Influence the Peptic Ulcer Market’s Path Forward?

To stay ahead in the peptic ulcer market, companies are creating novel products and solutions and getting them sanctioned by federal agencies. The role of drug development in controlling and treating peptic ulcers is pivotal; it assists with symptom management, healing, and prevention of complications while treating the root issue. For example, Akums Drugs and Pharmaceuticals Ltd., an Indian entity that specializes in pharmaceutical formulations and APIs, unveiled its latest product, Combikit, in April of 2023. This kit that consolidates Amoxicillin, Clarithromycin, and Esomeprazole got the nod from the Central Drugs Standard Control Organisation (CDSCO) for the treatment of Helicobacter pylori (H. pylori) associated duodenal ulcers and for wiping out H. pylori in patients with active or healed peptic ulcers. The treatment focusing on H. pylori has shown efficacy in dimming the chances of ulcer recurrence, providing substantial benefits to patients. H. pylori is an widespread infection in India that is tied up with gastritis and peptic ulcer development.

Secure Your Global Peptic Ulcer Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

How Are the Key Segments of the Peptic Ulcer Market Driving Opportunities and Innovations?

The peptic ulcer market covered in this report is segmented –

1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)

2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs

3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-Commerce

Subsegments:

1) By Gastritis: Acute Gastritis, Chronic Gastritis

2) By Gastric Ulcer: Acute Gastric Ulcer, Chronic Gastric Ulcer

3) By Duodenal Ulcer: Acute Duodenal Ulcer, Chronic Duodenal Ulcer

4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD, Erosive GERD

What Regions Are Steering Growth in the Peptic Ulcer Sector?

North America was the largest region in the peptic ulcer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Peptic Ulcer Market Classified and Defined in Market Analysis?

A peptic ulcer is an open sore or raw area in the stomach lining or intestine. It is primarily caused by the erosion of the stomach’s protective lining or the upper part of the small intestine (duodenum). The common peptic ulcer symptoms include upper abdominal pain or discomfort and acid reflux symptoms like heartburn, sometimes accompanied by nausea.

Browse Through More Similar Reports By The Business Research Company:

Ulcerative Colitis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ulcerative-colitis-global-market-report

Diabetic Foot Ulcer Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-global-market-report

Viral Hepatitis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: